Integrated Artificial Intelligence Screening to Optimize Patient Identification for Bronchoscopic Lung Volume Reduction Therapy: Redefining Patient Selection with SeleCT™ Screening

See how pilot programs at an academic center and a community hospital demonstrated how an AI-powered screening tool better identifies candidates for bronchoscopic lung volume reduction (BLVR). The result is improved access and accelerated time to intervention for patients with severe emphysema, as well as lowered burdens on healthcare systems.